Business · Brussels and Warsaw

Brussels court shields Polish air agency funds from Pfizer vaccine claim

A Brussels court of first instance has ruled that PAŻP's route-charge funds belong to the agency, not the State Treasury, and cannot be used to cover Pfizer's claims against Poland.

AI text based on reports by wpolityce.pl and Rzeczpospolita. Published . How it is made

For membersThe first 30 seconds for everyone. Synthetic voice (AI).

In brief

Brussels, Warsaw · Belgium, Poland
How it came to this
  1. 1 AprBelgian court rules for Pfizer, ordering Poland to take receipt of about 64 million doses and pay 5 billion 644 million zloty
  2. 1 JulEurocontrol informs PAŻP that accounts receiving navigation charges have been seized
  3. 12 NovBrussels first-instance court rules PAŻP's route-charge funds belong to the agency, not the State Treasury

The ruling

A first-instance court in Brussels ruled on Thursday, 12 November, that the money PAŻP collects from air navigation charges is the agency's own property. The court found that PAŻP is a separate legal entity with its own assets and independent financial management, so it is not liable for obligations of the State Treasury. On that basis, the funds cannot be used to satisfy Pfizer's claims against Poland.

“The court confirmed that funds from route charges belong to PAŻP, not to the State Treasury.”

Ministry of Health

Background to the dispute

The case concerns Covid-19 vaccines that Pfizer supplied and that Poland did not take receipt of. On 1 April, a Belgian court sided with the drugmaker and ordered Poland to take back about 64 million doses and pay it 5 billion 644 million zloty. On 1 July, Eurocontrol informed PAŻP that accounts receiving navigation charge income had been seized in connection with that ruling. Those accounts bring in more than 80% of the agency's revenue and are its main source of funding.

What comes next

The Ministry of Health said it is continuing to use its available legal remedies while respecting the competence and independence of Belgian courts. It has not disclosed details of its arguments or planned procedural steps, citing the ongoing proceedings. The Thursday ruling is a first-instance decision, and the wider dispute over the vaccines remains in the courts.

Ask about this text

Sources and context

Pollar is free and carries no ads in the text. Its members keep it going.

Support Pollar